Search results for "Transaminase"

showing 10 items of 145 documents

Hepatitis C Virus positive patients with persistently normal serum transaminase: a long-term follow-up

2010

hepatitis c persistently normal transaminase implicative statistical analyse
researchProduct

Chronic hepatitis C in children is a mild and curable liver disease

2011

Hepatitis C virus (HCV) infection is a major health problem orldwide, but children constitute only a small portion of infected atients. HCV transmission can occur through blood transfusion, nd the incidence of HCV infection was very high in children transused before 1990 for treatment of chronic haematological diseases 1] or other diseases that required blood transfusion [2]. Since he introduction of screening for HCV infection, blood transfusions ave become safe in developed countries, and the residual risk is oday very limited. In developed countries, maternal–fetal transmission has ecome themajor risk factor for HCV in children,with an estimated isk of infection ranging from 2% to 6% [3]…

medicine.medical_specialtyCirrhosisHepacivirusAntiviral AgentsGastroenterologychemistry.chemical_compoundLiver diseasechildrenInternal medicinemedicineHumansRisk factorChildHepatitisHepatologymedicine.diagnostic_testbusiness.industryRibavirinGastroenterologyAlanine TransaminaseHepatitis C Chronicmedicine.diseaseChronic infectionchemistryChild PreschoolLiver biopsyRNA ViralInterferonsTransient elastographybusinessDigestive and Liver Disease
researchProduct

Fibratos: efectos farmacológicos

2012

Fibrates have demonstrated efficacy in modifying the various parameters of atherogenic dyslipidemia. The best known fibrate is fenofibrate, which is indicated for the treatment of hypertriglyceridemia with or without low high-density lipoprotein cholesterol (HDL-c) and the treatment of atherogenic dyslipidemia in patients with statin intolerance or contraindications. Fenofibrate is also indicated in association with statins in patients with high cardiovascular risk when HDL-c and triglyceride (TG) concentrations are poorly controlled. The lipid-lowering effects of fenofibrate are mediated by activation of the nuclear transcription factor PPARα, which leads to an increase of lipolysis and pl…

medicine.medical_specialtyFenofibrateStatinTriglyceridebusiness.industrymedicine.drug_classCholesterolHypertriglyceridemiaFibratePharmacologymedicine.diseaseTransaminasechemistry.chemical_compoundEndocrinologychemistryInternal medicinemedicineLipolysislipids (amino acids peptides and proteins)Pharmacology (medical)Cardiology and Cardiovascular Medicinebusinessmedicine.drugClínica e Investigación en Arteriosclerosis
researchProduct

Liver injury in patients with severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysis.

2020

OBJECTIVE: Coronavirus disease-19 (COVID-19) infection is a global health threat. To inform the liver community on the potential relevance of COVID-19, we performed a systematic review and meta-analysis of published data on liver injury in patients with COVID-19 infection. METHODS: We searched PubMed and Google Scholar through 22 March according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Pooled data were analyzed by using random-effects meta-analyses. RESULTS: A total of 14 studies combining data from 2.871 patients were identified. The prevalence of pre-existing liver disease was reported at 3.1%. The pooled prevalence of elevated aspartate aminot…

medicine.medical_specialtyGastroenterology03 medical and health sciencesLiver disease0302 clinical medicineLiver Function TestsInternal medicinemedicineHumansClinical significanceAspartate AminotransferasesProspective cohort studyLiver injurybiologymedicine.diagnostic_testHepatologybusiness.industrySARS-CoV-2Liver DiseasesGastroenterologyCOVID-19Alanine Transaminasemedicine.diseaseConfidence intervalAlanine transaminaseLiver030220 oncology & carcinogenesisMeta-analysisbiology.protein030211 gastroenterology & hepatologyLiver function testsbusinessEuropean journal of gastroenterologyhepatology
researchProduct

Placenta-derived CD95 ligand causes liver damage in hemolysis, elevated liver enzymes, and low platelet count syndrome.

2004

Background & Aims: The HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome is a life-threatening complication during pregnancy. The associated liver disease may be severe, and maternal hepatic complications may progress to the point that transplantation becomes necessary. CD95 (APO-1, Fas)-mediated apoptosis of liver cells is one of the major pathogenic mechanisms during liver disease. The interaction of CD95 with its ligand, CD95L(FasL), induces apoptosis and thus the source of the death-inducing ligand is critical for understanding the pathomechanism of liver damage involving the CD95-system. Methods: Sera from HELLP patients were analyzed and used in cell culture experiment…

medicine.medical_specialtyHELLP SyndromeFas Ligand ProteinHELLP syndromePlacentaApoptosisBiologyHepatic ComplicationFas ligandAcute fatty liver of pregnancyLiver diseaseJurkat CellsMicePregnancyInternal medicinemedicineAnimalsHumansCells CulturedTransaminasesMembrane GlycoproteinsHepatologymedicine.diagnostic_testLiver cellGastroenterologymedicine.diseaseHemolysisMolecular WeightEndocrinologyLiverCancer researchHepatocytesFemaleLiver function testsGastroenterology
researchProduct

Imaging features of histological subtypes of hepatocellular carcinoma: Implication for LI-RADS

2021

Background & Aims The histopathological subtypes of hepatocellular carcinoma (HCC) are associated with distinct clinical features and prognoses. This study aims to report Liver Imaging Reporting and Data System (LI-RADS)-defined imaging features of different HCC subtypes in a cohort of resected tumours and to assess the influence of HCC subtypes on computed tomography (CT)/magnetic resonance imaging (MRI) LI-RADS categorisation in the subgroup of high-risk patients. Methods This retrospective institutional review board-approved study included patients with resected HCCs and available histopathological classification. Three radiologists independently reviewed preoperative CT and MRI exams. T…

medicine.medical_specialtyHepatocellular carcinomaALT alanine transaminaseComputed tomographyRC799-869AST aspartate aminotransferaseOS overall survivalHistopathological subtypeMagnetic resonance imagingNOS-HCC not otherwise specified hepatocellular carcinomaInternal MedicinemedicineImmunology and AllergyIn patientComputed tomographyLI-RADS Liver Imaging Reporting and Data SystemLiver imagingHepatologymedicine.diagnostic_testbiologyUS ultrasoundbusiness.industryNot Otherwise SpecifiedGastroenterologyTIV tumour-in-veinMagnetic resonance imagingHBP hepatobiliary phaseDiseases of the digestive system. Gastroenterologymedicine.diseasedigestive system diseasesHistopathological subtypesCT computed tomographyRFS recurrence-free survivalAlanine transaminaseHepatocellular carcinomaSH-HCC steatohepatitic hepatocellular carcinomaCohortMTM-HCC macrotrabecular-massive hepatocellular carcinomabiology.proteinLI-RADSRadiologyAPHE arterial phase hyperenhancementbusinessHCC hepatocellular carcinomaMRI magnetic resonance imagingResearch ArticleJHEP Reports
researchProduct

Viral clearance in HCV viraemic patients with normal alanine aminotransferase after combination therapy: a controlled, open-labelled study

2004

Summary Background : In patients with chronic hepatitis C virus infection and persistently normal alanine aminotransferase levels, liver fibrosis has been reported in 0–22% of cases and advanced liver disease in 5–10% of cases. Aim : To determine whether patients with persistently normal alanine aminotransferase levels clear infection after anti-viral therapy at equal or different rates from infected patients with raised alanine aminotransferase levels. Methods : Thirty-five hepatitis C virus RNA-positive patients with fibrosis at liver histology (Group 1) were matched for genotype, sex, age and histology with patients with raised alanine aminotransferase levels (Group 2). Both groups were …

medicine.medical_specialtyHepatologyCombination therapybiologybusiness.industryRibavirinHepatitis C virusGastroenterologyOdds ratiomedicine.disease_causemedicine.diseaseVirologyGastroenterologyConfidence intervalchemistry.chemical_compoundLiver diseaseAlanine transaminasechemistryFibrosisInternal medicinebiology.proteinmedicinePharmacology (medical)businessAlimentary Pharmacology & Therapeutics
researchProduct

Barbiturate jaundice

1969

Summary A case of barbital-induced jaundice is described. The patient, a 31-year-old woman, developed generalized skin eruption, mucosal lesions, and fever 2 hr after the ingestion of 2 tablets of a barbital-containing drug (Veramon). She then developed a deep cholestatic jaundice which lasted more than 7 months. During the remission of jaundice, a rechallenge with phenobarbital caused a recurrence of fever and skin eruption, with exacerbation of jaundice.

medicine.medical_specialtyHepatologybiologyExacerbationmedicine.diagnostic_testbusiness.industrymedicine.drug_classGastroenterologyJaundiceBarbitalGastroenterologyAlanine transaminaseBarbiturateAnesthesiaInternal medicinebiology.proteinMedicineIngestionPhenobarbitalmedicine.symptombusinessLiver function testsmedicine.drugGastroenterology
researchProduct

Long-Term Evaluation of a Rat Model of Chronic Cholangitis Resembling Human Primary Sclerosing Cholangitis

2003

Primary sclerosing cholangitis (PSC) is a chronic cholestatic disorder with a presumed autoimmune aetiopathogenesis. We have recently described a novel organ-specific rat model of fibrosing cholangitis induced by intrabiliary administration of the hapten-reagent 2,4,6-trinitrobenzenesulfonic acid (TNBS) with similarities to human PSC. In the present report, we have evaluated the long-term outcome of TNBS-induced cholangitis in this model. Mild stenosis of the common bile duct of female Lewis rats (n = 18) was achieved by subtotal ligation and cholangitis induced by TNBS injection (50 mg/kg) into the dilated bile duct after a second laparotomy. After 8 and 12 months, we found no evidence of …

medicine.medical_specialtyPathologyNecrosisCholangitis SclerosingImmunologyInflammationdigestive systemGastroenterologyAntibodies Antineutrophil CytoplasmicPrimary sclerosing cholangitisCholangiographyInternal medicinemedicineAnimalsHumansChronic CholangitisAnti-neutrophil cytoplasmic antibodymedicine.diagnostic_testCommon bile ductbusiness.industryAlanine TransaminaseGeneral Medicinemedicine.diseaseRatsDisease Models AnimalC-Reactive Proteinmedicine.anatomical_structureLiverTrinitrobenzenesulfonic AcidRats Inbred LewChronic DiseaseDisease ProgressionFemalemedicine.symptomLigationbusinessScandinavian Journal of Immunology
researchProduct

Implication of Normal Liver Enzymes in Liver Disease

2009

Summary.  Chronic liver disease is usually asymptomatic until its late stages and also significant hepatic necroinflammation and fibrosis may be present in persistently normal ALT levels HBV, HCV carriers or similarly, in patients with nonalcoholic fatty liver disease. Given the large number of persons in the general population which may harbor a clinically significant liver disease behind the screen of normal alanine aminotransferase, more attention should be devoted to future research for alternative noninvasive markers of liver damage.

medicine.medical_specialtyPopulationChronic liver diseaseaminotransferases chronic hepatitis liver fibrosisGastroenterologySensitivity and SpecificityLiver diseaseVirologyInternal medicineNonalcoholic fatty liver diseasemedicineHumanseducationeducation.field_of_studyHepatologymedicine.diagnostic_testbusiness.industryLiver DiseasesFatty liverAlanine TransaminaseHepatitis Cmedicine.diseaseInfectious DiseasesLiverHepatic fibrosisLiver function testsbusiness
researchProduct